CASC3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.537700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.615600E-01
Normal-vs-Stage2
6.601900E-02
Normal-vs-Stage3
4.598000E-02
Normal-vs-Stage4
6.120200E-01
Stage1-vs-Stage2
2.611000E-01
Stage1-vs-Stage3
1.214970E-01
Stage1-vs-Stage4
5.637000E-01
Stage2-vs-Stage3
1.420560E-01
Stage2-vs-Stage4
4.10849999999963E-05
Stage3-vs-Stage4
4.828200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.455900E-02
Normal-vs-AfricanAmerican
3.016200E-01
Normal-vs-Asian
1.001200E-01
Caucasian-vs-AfricanAmerican
4.290400E-01
Caucasian-vs-Asian
6.480000E-01
AfricanAmerican-vs-Asian
3.392000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.085640E-01
Normal-vs-Female
8.998000E-02
Male-vs-Female
9.875400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.437200E-01
Normal-vs-Age(41-60Yrs)
1.977150E-01
Normal-vs-Age(61-80Yrs)
6.878300E-02
Normal-vs-Age(81-100Yrs)
6.119600E-03
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.526000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.939600E-02
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.873600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.287760E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.967730E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.187200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.835900E-02
Normal-vs-Daily Drinker
1.946300E-02
Normal-vs-Weekly Drinker
8.510400E-02
Normal-vs-Occasional Drinker
2.452400E-01
Normal-vs-Social Drinker
3.979200E-01
Non Drinker-vs-Daily Drinker
8.452800E-01
Non Drinker-vs-Weekly Drinker
5.911600E-01
Non Drinker-vs-Occasional Drinker
7.614000E-02
Non Drinker-vs-Social Drinker
3.887700E-02
Daily Drinker-vs-Weekly Drinker
4.563800E-01
Daily Drinker-vs-Occasional Drinker
4.448000E-02
Daily Drinker-vs-Social Drinker
2.184000E-02
Weekly Drinker-vs-Occasional Drinker
2.860400E-01
Weekly Drinker-vs-Social Drinker
1.694440E-01
Occasional Drinker-vs-Social Drinker
6.669400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.504200E-02
Normal-vs-Grade 2
8.760700E-03
Normal-vs-Grade 3
2.036900E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.749400E-01
Grade 1-vs-Grade 3
5.424200E-01
Grade 1-vs-Grade 4
5.504200E-02
Grade 2-vs-Grade 3
6.446200E-01
Grade 2-vs-Grade 4
8.760700E-03
Grade 3-vs-Grade 4
2.036900E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.338200E-02
Normal-vs-NonDiabetic
1.164810E-01
Diabetic-vs-NonDiabetic
1.144200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.234200E-01
Normal-vs-NoPancreatitis
7.769900E-02
Pancreatitis-vs-NoPancreatitis
6.317200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.644190E-01
Normal-vs-N1
6.305700E-02
N0-vs-N1
4.164000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.143650E-01
Normal-vs-TP53-NonMutant
4.142600E-01
TP53-Mutant-vs-TP53-NonMutant
1.257960E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
